Loading company details...
Beta
Latest Form 4 (Aug 18, 2026): Jason Lettmann (CHIEF EXECUTIVE OFFICER): Sale of 2,230 shares, $4.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2026 | Jason Lettmann, CHIEF EXECUTIVE OFFICER | Sale | 2,230 | $4.3K |
| Aug 18, 2026 | Shelly Wong, SVP, FINANCE AND CAO | Sale | 573 | $1.1K |
| Jul 6, 2026 | Shelly Wong, SVP, FINANCE AND CAO | Sale | 1,404 | $2.9K |
| Apr 17, 2026 | Jeff E. Knight, Chief Dev & Operating Officer | Grant/Award | 800,000 | n/a |
| Apr 17, 2026 | Barbara Klencke, Chief Medical Officer | Grant/Award | 100,000 | n/a |
| Mar 23, 2026 | Jason Lettmann, CHIEF EXECUTIVE OFFICER | Sale | 12,311 | $26.7K |
| Mar 23, 2026 | Shelly Pinto, SVP, FINANCE AND CAO | Sale | 903 | $2.0K |
| Mar 5, 2026 | Barbara Klencke, Chief Medical Officer | Grant/Award | 700,000 | n/a |
| Feb 20, 2026 | Shelly Pinto, SVP, FINANCE AND CAO | Sale | 565 | $1.3K |
| Feb 20, 2026 | Jason Lettmann, CHIEF EXECUTIVE OFFICER | Tax Withholding | 2,201 | $5.0K |